MCL1 and metabolic dysfunction-associated steatohepatitis: Thus, this study provides evidence that excessive hepatocyte apoptosis is tumor promoting also in fatty liver disease and the anti-apoptotic protein Mcl1 is tumor suppressive in mouse liver affected by NASH.